Edward R. Kost

Oncology
903 W Martin St
San Antonio, TX 78207

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Regional and statewide hysterectomy-corrected endometrial cancer incidence and five-year relative survival in Texas.

Regional and statewide hysterectomy-corrected endometrial cancer incidence and five-year relative survival in Texas.

Journal: Cancer epidemiology
Published: April 21, 2026

Therapeutic optimization of LIPA targeting to induce endoplasmic reticulum stress and cell death in ovarian cancer.

Therapeutic optimization of LIPA targeting to induce endoplasmic reticulum stress and cell death in ovarian cancer.

Journal: Oncogene
Published: October 14, 2025

EC359 Enhances Trametinib Efficacy in Ras/Raf-Driven Ovarian Cancer by Suppressing LIFR Signaling.

EC359 Enhances Trametinib Efficacy in Ras/Raf-Driven Ovarian Cancer by Suppressing LIFR Signaling.

Journal: Biomolecules
Published: August 06, 2025

Saturation of respiratory strain during robotic hysterectomy in obese women with endometrial cancer.

Saturation of respiratory strain during robotic hysterectomy in obese women with endometrial cancer.

Journal: Journal of robotic surgery
Published: July 24, 2025

Significance of LIF/LIFR Signaling in the Progression of Obesity-Driven Triple-Negative Breast Cancer.

Significance of LIF/LIFR Signaling in the Progression of Obesity-Driven Triple-Negative Breast Cancer.

Journal: Cancers
Published: August 11, 2024

PAI-1 uncouples integrin-β1 from restrain by membrane-bound β-catenin to promote collagen fibril remodeling in obesity-related neoplasms.

PAI-1 uncouples integrin-β1 from restrain by membrane-bound β-catenin to promote collagen fibril remodeling in obesity-related neoplasms.

Journal: Cell reports
Published: April 10, 2024

KDM1A/LSD1 inhibition enhances chemotherapy response in ovarian cancer.

KDM1A/LSD1 inhibition enhances chemotherapy response in ovarian cancer.

Journal: Molecular carcinogenesis
Published: April 03, 2024

Novel LIPA-Targeted Therapy for Treating Ovarian Cancer.

Novel LIPA-Targeted Therapy for Treating Ovarian Cancer.

Journal: Cancers
Published: December 30, 2023

Pharmacological inhibition of the LIF/LIFR autocrine loop reveals vulnerability of ovarian cancer cells to ferroptosis.

Pharmacological inhibition of the LIF/LIFR autocrine loop reveals vulnerability of ovarian cancer cells to ferroptosis.

Journal: NPJ precision oncology
Published: December 21, 2023

The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling.

The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling.

Journal: International journal of molecular sciences
Published: October 28, 2023

Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer.

Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer.

Journal: Cancer letters
Published: June 19, 2023

PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis.

PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis.

Journal: Molecular oncology
Published: April 18, 2023
Showing 1-12 of 23

Last Updated: 09/26/2026